Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-03

Clinical Trial Update: A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y [Phase 2]

View source ↗

Summary

A Phase 2 trial of GRT3983Y for painful diabetic neuropathy was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GRT3983Y

Snippet

Sponsor: Grünenthal GmbH | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2012-05-03